[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also…
Tag: Health care industry
Patients regain weight after stopping Eli Lilly’s Zepbound, study says
[ad_1] Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took Eli Lilly‘s weight loss drug Zepbound regained around half the…
Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback
[ad_1] Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements…
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
[ad_1] Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test. Md Babul Hosen | Istock | Getty Images The U.S. Food and…
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
[ad_1] At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a…
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1] A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for…
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
[ad_1] The FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy. Courtesy: Eli Lilly Eli Lilly on Tuesday said its recently approved weight loss treatment…